Iproheptine

Last updated

Iproheptine
Iproheptine.png
Clinical data
Trade names Metron, Susat
Other namesN-Isopropyl-1,5-dimethylhexylamine; N-Isopropyloctodrine
Identifiers
  • 6-methyl-N-propan-2-ylheptan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.034.283 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C11H25N
Molar mass 171.328 g·mol−1
3D model (JSmol)
  • CC(C)CCCC(C)NC(C)C
  • InChI=1S/C11H25N/c1-9(2)7-6-8-11(5)12-10(3)4/h9-12H,6-8H2,1-5H3 Yes check.svgY
  • Key:NKGYBXHAQAKSSG-UHFFFAOYSA-N Yes check.svgY

Iproheptine, also known as N-isopropyl-1,5-dimethylhexylamine or N-isopropyloctodrine and sold under the brand names Metron and Susat, is a nasal decongestant which has been marketed in Japan. [1] [2] [3] It is described as a vasoconstrictor and antihistamine. [1] [2] [3] The drug is available over-the-counter in Japan. [4]

Contents

Pharmacology

Pharmacodynamics

Iproheptine is described as a decongestant, vasoconstrictor, and antihistamine. [1] [2] [3] Its pharmacology was characterized in a series of several preclinical studies published in the 1960s. [5] [6] [7] [8] [9] [10]

The drug was found to have anticholinergic- and antihistamine-like effects that were described as more potent than those of ephedrine. [6] [8] [10] It was said to have hypotensive and cardiac inhibitive actions that made it differ from other known alkylamine and arylalkylamine sympathomimetics. [6] [8] The effects of iproheptine on blood vessels, pupils, and saliva secretion were all said to be very weak. [6] It produced bronchodilation, vasoconstriction, and hemostasis similarly to ephedrine or methoxyphenamine. [7] [10] Iproheptine showed no effect against hexobarbital-induced sleep. [7] Conversely, it showed an antidepressant- or stimulant-like effect in the forced swim test (FST). [9]

Close analogues of iproheptine, such as methylhexanamine and tuaminoheptane, are known to act as norepinephrine and/or dopamine releasing agents by interacting with the monoamine transporters, and this is thought to underlie their sympathomimetic and stimulant effects. [11] [12] [13] [14] [15] [16]

Pharmacokinetics

In contrast to arylalkylamines like phenethylamines and tryptamines, iproheptine is not metabolized by monoamine oxidase (MAO). [9]

Chemistry

Iproheptine, also known as N-isopropyl-1,5-dimethylhexylamine or as N-isopropyloctodrine, is an alkylamine and the N-isopropyl derivative of octodrine (2-amino-6-methylheptane or 1,5-dimethylhexylamine (1,5-DMHA)). [1] [2] [3]

Aside from octodrine, it is also closely structurally related to other alkylamines, including 1,3-dimethylbutylamine (1,3-DMBA), 1,4-dimethylamylamine (1,4-DMAA), heptaminol (2-methyl-6-amino-2-heptanol), isometheptene (2-methyl-6-methylamino-2-heptene), methylhexanamine (1,3-dimethylamylamine (1,3-DMAA)), and tuaminoheptane (tuamine; 2-aminoheptane or 1-methylhexylamine). [1] [2] [3]

Iproheptine shows structural similarity to what would be 3- or 4-methyl-N-isopropylamphetamine, but with the equivalent of the phenyl ring open and incomplete (i.e., missing two carbon atoms, saturated, and the carbons not connected to form a ring). [17] [1]

The predicted log P (XLogP3) of iproheptine is 3.6. [17]

History

Iproheptine was first described in the scientific literature by 1960 [5] [6] and was first patented by 1962. [1] It remained marketed in Japan in 2004. [2]

Society and culture

Names

Iproheptine is the generic name of the drug and its INN Tooltip International Nonproprietary Name. [1] [2] In the case of the hydrochloride salt, its generic name is iproheptine hydrochloride and this is its JAN Tooltip Japanese Accepted Name. [2] The drug is marketed under the brand names Metron and Susat (both as the hydrochloride salt). [1] [2]

Availability

Iproheptine appears to have been marketed only in Japan. [2] It is available over-the-counter in this country. [4]

See also

References

  1. 1 2 3 4 5 6 7 8 9 Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 802. ISBN   978-1-4757-2085-3 . Retrieved 30 August 2024.
  2. 1 2 3 4 5 6 7 8 9 10 Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 656. ISBN   978-3-88763-101-7 . Retrieved 30 August 2024.
  3. 1 2 3 4 5 Milne GW (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. p. 286. ISBN   978-1-351-78990-5 . Retrieved 30 August 2024. Iproheptine 13946-02-6 6243 CHAN N-Isopropyl-1,5-dimethylhexylamine. Metron; Metron S. Antihistaminic.
  4. 1 2 "KEGG DRUG: Iproheptine Hydrochloride". GenomeNet. Retrieved 30 August 2024.
  5. 1 2 Ota Y, Otani G, Enomoto R (1960). "Pharmacological Studies on Alkylaminoheptane Derivatives. I: Tracheal Muscle Spasmolytic Action of N-Alkyl-1, 5-dimethylhexylamine Derivatives". Yakugaku Zasshi. 80 (9): 1153–1155. doi: 10.1248/yakushi1947.80.9_1153 . ISSN   0031-6903.
  6. 1 2 3 4 5 Ota Y, Enomoto R, Ishiguro Y (1960). "Pharmacological Studies on Alkylaminoheptane Derivatives. II: Pharmacological Action of N-Isopropyl-1, 5-dimethylhexylamine Hydrochloride. (1)". Yakugaku Zasshi. 80 (9): 1156–1159. doi: 10.1248/yakushi1947.80.9_1156 . ISSN   0031-6903.
  7. 1 2 3 Ota Y, Fuchibe K, Takahashi M (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. III: Pharmacological Action of N-Isopropyl-1, 5-dimethylhexylamine Hydrochloride. (2)". Yakugaku Zasshi. 81 (3): 394–402. doi: 10.1248/yakushi1947.81.3_394 . ISSN   0031-6903.
  8. 1 2 3 Ota Y (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. IV: Blood Pressor, Antispasmodic and Capillary Permeability Inhibiting Action of N-Alkyl-1, 5-dimethylhexylamine Derivatives". Yakugaku Zasshi. 81 (3): 403–407. doi: 10.1248/yakushi1947.81.3_403 . ISSN   0031-6903.
  9. 1 2 3 Ota Y, Watabe M, Takahashi M (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. V: Pharmacological Action of N-isopropyl-1, 5-dimethylhexylamine Hydrochloride. (3)". Yakugaku Zasshi. 81 (3): 407–414. doi: 10.1248/yakushi1947.81.3_407 . ISSN   0031-6903.
  10. 1 2 3 Ota Y (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. VI: Pharmacological Action of N-Isopropyl-1, 5-dimethyl-hexylamine Hydrochloride. (4)". Yakugaku Zasshi. 81 (3): 415–420. doi: 10.1248/yakushi1947.81.3_415 . ISSN   0031-6903.
  11. ↑ Small C, Cheng MH, Belay SS, Bulloch SL, Zimmerman B, Sorkin A, et al. (August 2023). "The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization". J Pharmacol Exp Ther. 386 (2): 266–273. doi:10.1124/jpet.122.001573. PMC   10353075 . PMID   37348963.
  12. ↑ Docherty JR (June 2008). "Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)". Br J Pharmacol. 154 (3): 606–622. doi:10.1038/bjp.2008.124. PMC   2439527 . PMID   18500382.
  13. ↑ Delicado EG, Fideu MD, Miras-Portugal MT, Pourrias B, Aunis D (August 1990). "Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells". Biochem Pharmacol. 40 (4): 821–825. doi:10.1016/0006-2952(90)90322-c. PMID   2386550.
  14. ↑ Alsufyani HA, Docherty JR (January 2019). "Methylhexaneamine causes tachycardia and pressor responses indirectly by releasing noradrenaline in the rat". Eur J Pharmacol. 843: 121–125. doi:10.1016/j.ejphar.2018.10.047. PMID   30395850.
  15. ↑ Schlessinger A, Geier E, Fan H, Irwin JJ, Shoichet BK, Giacomini KM, et al. (September 2011). "Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET". Proc Natl Acad Sci U S A. 108 (38): 15810–15815. Bibcode:2011PNAS..10815810S. doi: 10.1073/pnas.1106030108 . PMC   3179104 . PMID   21885739.
  16. ↑ Rickli A, Hoener MC, Liechti ME (September 2019). "Pharmacological profiles of compounds in preworkout supplements ("boosters")". Eur J Pharmacol. 859 172515. doi:10.1016/j.ejphar.2019.172515. PMID   31265842.
  17. 1 2 "Iproheptine". PubChem. Retrieved 8 December 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.